Alpha Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25,803	Closed	-$1.35M	–	119
2025 Q4	$1.35M	Buy	25,803 +17,718	+219%	+$1.06M	0.19%	73
2025 Q3	$524K	Buy	+8,085	New	+$464K	0.08%	93
2025 Q2	–	Sell	-12,223	Closed	-$416K	–	117
2025 Q1	$416K	Buy	+12,223	New	+$518K	0.08%	94
2024 Q3	–	Sell	-36,636	Closed	-$1.98M	–	113
2024 Q2	$1.98M	Sell	36,636 -7,610	-17%	-$440K	0.39%	65
2024 Q1	$3.02M	Sell	44,246 -492	-1%	-$35.2K	0.59%	63
2023 Q4	$2.8M	Sell	44,738 -1,411	-3%	-$78K	0.58%	62
2023 Q3	$2.09M	Buy	46,149 +13,208	+40%	+$682K	0.49%	66
2023 Q2	$1.34M	Hold	32,941	–	–	0.33%	74
2023 Q1	$1.34M	Hold	32,941	–	–	0.33%	74
2022 Q4	$1.34M	Buy	32,941 +2,823	+9%	+$150K	0.33%	74
2022 Q3	$1.97M	Buy	30,118 +3,213	+12%	+$233K	0.52%	67
2022 Q2	$1.64M	Buy	26,905 +3,581	+15%	+$211K	0.45%	68
2022 Q1	$1.46M	Buy	23,324 +852	+4%	+$53.5K	0.32%	73
2021 Q4	$1.7M	Sell	22,472 -2,419	-10%	-$211K	0.38%	70
2021 Q3	$2.79M	Sell	24,891 -569	-2%	-$71.5K	0.66%	54
2021 Q2	$4.12M	Buy	25,460 +17,118	+205%	+$2.08M	0.97%	30
2021 Q1	$1.02M	Buy	8,342 +3,164	+61%	+$478K	0.26%	79
2020 Q4	$793K	Buy	+5,178	New	+$612K	0.2%	79